Recent ARTL News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:01:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 01:00:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2026 09:38:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2026 09:10:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 10:16:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/07/2026 09:05:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 09:17:04 PM
- Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate • GlobeNewswire Inc. • 12/23/2025 02:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 12/11/2025 09:14:35 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/11/2025 09:05:26 PM
- Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical • GlobeNewswire Inc. • 12/03/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 09:05:41 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/17/2025 09:56:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 01:01:01 PM
- Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/12/2025 01:00:00 PM
- Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer • GlobeNewswire Inc. • 11/04/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 12:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2025 12:00:51 PM
- Artelo Biosciences Names Veteran Life Sciences Executive Mark Spring, CPA, as Chief Financial Officer • GlobeNewswire Inc. • 10/27/2025 12:00:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/21/2025 09:48:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2025 08:30:34 PM
LaFleur Minerals Reports Assay Results Highlighting 2.05 g/t Au over 158.25 metres, Confirming Strong Gold Continuity at Swanson Gold Project • LFLRF • Feb 5, 2026 5:29 AM
DRCR Begins Rollout of New Business Model • DRCR • Feb 4, 2026 12:42 PM
BIO-PATH HOLDINGS ANNOUNCES "BPTH 2.0" STRATEGIC PIVOT ON WORLD CANCER DAY; ENGAGES LEGAL COUNSEL FOR REGULATION A OFFERING • BPTH • Feb 4, 2026 10:00 AM
Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • BLEG • Feb 4, 2026 9:07 AM
ConnectM Subsidiary Signs Definitive Agreement with Alpex Solar to Execute Solar Deployments Worth an Initial ~$16.5M • CNTM • Feb 4, 2026 9:05 AM
The Hidden Revenue Drain in Hospitality-and How AI Robotics Is Finally Closing the Gap • NGTF • Feb 4, 2026 9:00 AM
